Refine
Year of publication
Language
- English (41)
Has Fulltext
- yes (41)
Is part of the Bibliography
- no (41)
Keywords
- Health care (2)
- Multimorbidity (2)
- Multiple chronic conditions (2)
- Polypharmacy (2)
- Adhesion (1)
- Advanced breast cancer (1)
- Antihormone therapy (1)
- BG-index (1)
- Biochemistry (1)
- Bipolar disorder (1)
- Breast cancer (1)
- COVID-19 (1)
- CVID (1)
- CXCL12 (1)
- CXCR4 (1)
- Cardiology (1)
- Clinical variation (1)
- Completed suicide (1)
- Depression (1)
- Digital breast tomosynthesis (DBT) (1)
- Digital mammography (1)
- Elderly (1)
- European Society for Immunodeficiencies (ESID) (1)
- Frailty (1)
- General practice (1)
- General practitioners (1)
- Genetics (1)
- German PID-NET registry (1)
- HER2 c-erbB2 (1)
- HER2/neu (1)
- Health services (1)
- Heregulin (1)
- Hypertension (1)
- IgG substitution therapy (1)
- Immunology (1)
- KCGS (1)
- MACE (1)
- MM-121 (1)
- Medication changes (1)
- Metastatic (1)
- NXF1 (1)
- Neuroscience (1)
- Older adults (1)
- Oldest-old (1)
- Oncology (1)
- PID prevalence (1)
- Pandemic (1)
- Patients (1)
- Population-based screening (1)
- Primary health care (1)
- RNA Biology (1)
- Recall rate (1)
- Red blood cell transfusion (1)
- SARS-CoV2 (1)
- SR protein (1)
- SRSF3 (1)
- SRSF7 (1)
- Seribantumab (1)
- Suicide attempt (1)
- T-DM1 (1)
- academic medicine (1)
- advanced breast cancer (1)
- alternative 3′ end processing (1)
- anaemia (1)
- antihormone therapy (1)
- atherosclerosis (1)
- cardiovascular disease (1)
- career promotion (1)
- chemogenomic set (1)
- chemotherapy (1)
- drug discovery (1)
- druggable genome (1)
- elderly patients (1)
- epigenetics (1)
- gender difference (1)
- hemodialysis (1)
- iCLIP (1)
- integrins (1)
- iron deficiency (1)
- kidney disease (1)
- kinase inhibitor (1)
- lapatinib (1)
- mRNA export (1)
- medical error (1)
- metastatic (1)
- miRNA (1)
- next-generation sequencing (1)
- patient blood management (1)
- patient safety (1)
- pertuzumab (1)
- phenotypic screening (1)
- preoperative anaemia management (1)
- primary health care (1)
- primary immunodeficiency (PID) (1)
- promotion index (1)
- prostate carcinoma cells (1)
- protein kinase (1)
- registry for primary immunodeficiency (1)
- risk management (1)
- small molecules (1)
- surgery (1)
- trastuzumab (1)
- understudied kinase (1)
Institute
- Medizin (41) (remove)
Epigenetic dysregulation contributes to the high cardiovascular disease burden in chronic kidney disease (CKD) patients. Although microRNAs (miRNAs) are central epigenetic regulators, which substantially affect the development and progression of cardiovascular disease (CVD), no data on miRNA dysregulation in CKD-associated CVD are available until now. We now performed high-throughput miRNA sequencing of peripheral blood mononuclear cells from ten clinically stable hemodialysis (HD) patients and ten healthy controls, which allowed us to identify 182 differentially expressed miRNAs (e.g., miR-21, miR-26b, miR-146b, miR-155). To test biological relevance, we aimed to connect miRNA dysregulation to differential gene expression. Genome-wide gene expression profiling by MACE (Massive Analysis of cDNA Ends) identified 80 genes to be differentially expressed between HD patients and controls, which could be linked to cardiovascular disease (e.g., KLF6, DUSP6, KLF4), to infection / immune disease (e.g., ZFP36, SOCS3, JUND), and to distinct proatherogenic pathways such as the Toll-like receptor signaling pathway (e.g., IL1B, MYD88, TICAM2), the MAPK signaling pathway (e.g., DUSP1, FOS, HSPA1A), and the chemokine signaling pathway (e.g., RHOA, PAK1, CXCL5). Formal interaction network analysis proved biological relevance of miRNA dysregulation, as 68 differentially expressed miRNAs could be connected to 47 reciprocally expressed target genes. Our study is the first comprehensive miRNA analysis in CKD that links dysregulated miRNA expression with differential expression of genes connected to inflammation and CVD. After recent animal data suggested that targeting miRNAs is beneficial in experimental CVD, our data may now spur further research in the field of CKD-associated human CVD.